INSPIRE LAUNCHES NEW APP!

January 23, 2020

Inspire is a free and secure online support community in which patients connect with one another for support and information. ACPMP has been a partner with Inspire for the past 10 years and has cultivated a wonderful support community for appendix cancer and PMP patients with over 1,900 members! We are excited to share with you Inspire's new mobile app!...

ACPMP ANNOUNCES PARTNERSHIP WITH MYPART NETWORK AT THE U.S. NATIONAL CANCER INSTITUTE’S CENTER FOR CANCER RESEARCH

December 17, 2019

The ACPMP Research Foundation is excited to announce that we have become official advocacy partners of the MyPART Network at the U.S. National Cancer Institute’s Center for Cancer Research! The My Pediatric and Adult Rare Tumor (MyPART) Network is a group of patients, family members, researchers, advocates, and healthcare providers who are working together to find treatments for childhood, teen,...

ACPMP RAISES OVER $35,000 ON GIVING TUESDAY 2019

December 11, 2019

ACPMP celebrated #GivingTuesday 2019 by sharing videos from our Board of Directors and staff in the week leading up to it! Their stories will tug at your heartstrings when you learn how they all have been individually impacted by Appendix Cancer/PMP. We hope these videos inspired you, gave you hope, and showed you just how personal this fight truly is...

NCI REACHES OUT TO ACPMP FOR ASSISTANCE WITH NEW CLINICAL STUDY

November 6, 2019

The ACPMP Research Foundation continues to follow with great interest the clinical research being conducted to identify appendiceal tumor characteristics against which novel drugs can be targeted to reduce, if not eliminate, disease.  We were pleased, therefore, with the recent addition to our website’s list of clinical trials of a currently recruiting Phase 1 clinical study of patients with solid...

GRANT RECIPIENTS & MEMORIAL DESIGNEES: ACPMP 2018 GRANT CYCLE

August 23, 2019

The Appendix Cancer / Pseudomyxoma Peritonei Research Foundation (ACPMP) is pleased to announce the recipients of our 2018 research grant cycle. With these two grants, ACPMP has now issued $1,200,000 in the form of 25 promising research grants over the past 10 years designed to improve the diagnosis and treatment of Appendix Cancer and Pseudomyxoma Peritonei. These grants are issued...

ACPMP 2018 IMPACT REPORT

May 16, 2019

The ACPMP Research Foundation is committed to financial transparency. We want our donors to know how every dollar they donate is spent. Our 2018 IRS Form 990 and Reviewed Financial Statements are available for review at our Donor Confidence page, and our 2018 Impact Report shows what we achieved in 2018. We are proud to once again be a Platinum Level Participant on the GuideStar Exchange,...

REGIONAL CANCER THERAPIES 2019: ACPMP RECAP

April 4, 2019

The Appendix Cancer / Pseudomyxoma Peritonei Research Foundation (ACPMP) sponsored and participated in the 14th Annual International Symposium on Regional Cancer Therapies, presented by the Society of Surgical Oncology, which took place from February 16-18, 2019 at the Arizona Grand Resort in Phoenix, AZ. ACPMP expanded our investment in this exciting event by providing funding for three travel scholarships enabling young physicians...

UPDATE ON AUSTRALIAN PHASE I CLINICAL TRIAL

March 12, 2019

Professor David Morris joined ACPMP for Rare Disease Day on February 28, 2019 to provide an update on the research funded by ACPMP in 2016 that has led to a Phase I clinical trial.

DR. LAMBERT NAMED CHAIR; DR. MISDRAJI AND DR. SWITZER JOIN ACPMP MEDICAL ADVISORY BOARD

February 21, 2019

Addition of pathologist and medical oncologist expand breadth of expertise The Appendix Cancer / Pseudomyxoma Peritonei Research Foundation (ACPMP) is delighted to announce that Laura Lambert, MD, FACS has been appointed Chair of the ACPMP Medical Advisory Board.  ACPMP is also pleased to welcome Joseph Misdraji, MD and Bradley Switzer, MD as members of the ACPMP Medical Advisory Board. Dr. Lambert...

CALLING ALL SURVIVORS!

December 21, 2018

By funding research grants through NORD, partnering with specialists for education, and providing information to those who reach out to us and visit our website, our organization exists to help you. With new initiatives in the works, we are working hard to offer hope to patients and their families.